Fig. 2From: Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASERKaplan-Meier survival curves. a Drug survival estimates by age (p = 0.02). b Drug survival estimates by monotherapy or combined therapy (p = 0.52). c Drug survival estimates by non-tumor necrosis factor inhibitor (non-TNFi) or TNF-i, only considering first and second lines of treatment (p = 0.06)Back to article page